Publications by authors named "G Mattingly"

Claim this Profile
V
Vortioxetine in treatment of depression with somatic comorbidities in routine practice: sub-group analysis of the RELIEVE study.
David S Baldwin, Amar Mehta, Daniel Oudin Åström, Elin H Reines, GregoryW Mattingly

J Affect Disord· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes and discharge disposition in nonagenarians with ST-elevation myocardial infarction.
Janki Shukla, Christian Schmidt, David Larson, Avinash Murthy, Jenny Chambers, Georgia Mattingly

Am Heart J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder.
Gregory W Mattingly, Osman Turkoglu, Denise Chang, Caroline Ward, Taisa Skubiak

J Clin Psychopharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Adam Janik, Xin Qiu, Rosanne Lane, Vanina Popova, Wayne C Drevets, Gregory W Mattingly

JAMA Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis.
Joshua M Hamilton, Karen L Johnston, James Simples Jnr, Ibrahim Turkoz, Lisa Lim, Gregory Mattingly

Neuropsychiatr Dis Treat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis